Knauf to acquire USG Corporation in $7 billion deal - Chicago Business Journal
McAfee Rebuts Dimon: Crypto-Currencies 'Not a Fraud' | Barron's
J&J chief Gorsky, in China for official summit, straddles Trump's globalism divide | Fierce Pharma
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
So These Guys Are Back on CNBC
Amazon finds it's not so easy to sell drugs—and nixes one plan entirely: CNBC | Fierce Pharma
Teva Pharmaceuticals - Crunchbase Company Profile & Funding
Teva Surges After Warren Buffett's Berkshire Reports $358M Stake | BioSpace
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Future Of Work And More With Sam Caucci, Founder Of 1huddle | 1Huddle
Teva Pharmaceutical shares jump after Goldman upgrades embattled drugmaker, predicts turnaround
Warren Buffett's Berkshire dumps IBM, buys Teva as Apple becomes top investment - BNN Bloomberg
New & Notable: Amazon tablets, Samsung laptops, Teva sandals
Watch CNBC's full interview with Teva CEO Kåre Schultz
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
CNBC on Twitter: "BREAKING: Warren Buffett's Berkshire Hathaway takes stake in Teva Pharma.; stock jumps after-hours. https://t.co/YKho1O67Ek https://t.co/bn0ijczjFc" / Twitter
Buffett adds Teva in 13F filing
A Look At Kare Schultz, The New CEO In Charge Of Teva
/cloudfront-us-east-2.images.arcpublishing.com/reuters/C2FXYGCZKBJO5LQTP6GT4E2CGA.jpg "Warren Buffett says Greg Abel would become Berkshire CEO after he's gone - CNBC | Reuters")
Warren Buffett says Greg Abel would become Berkshire CEO after he's gone - CNBC | Reuters
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Rick Santelli walks off CNBC- POLITICO
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
CNBC-TV18 on Twitter: "EXCL Intas Pharma bags deal worth over $ 750 mn in Europe. Binish Chudgar, Co MD shares the future strategies of the co with @PoddarNisha. https://t.co/MHmrIaYyqM" / Twitter
Roche says 'no thanks' to megadeals, but don't count out smaller M&A | Fierce Pharma
